Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 09, 2020 16:05 ET | Source: Organogenesis Holdings Inc.

Organogenesis Holdings Inc. Reports Fourth Quarter and Fiscal Year 2019 Financial Results; Introduces Fiscal Year 2020 Revenue Guidance

CANTON, Mass., March 09, 2020 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization...
February 21, 2020 07:30 ET | Source: Organogenesis Holdings Inc.

Organogenesis Holdings Inc. to Present at the 9th Annual SVB Leerink Global Healthcare Conference

CANTON, Mass., Feb. 21, 2020 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of...
January 23, 2020 16:05 ET | Source: Organogenesis Holdings Inc.

Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2019 Financial Results on March 9, 2020

CANTON, Mass., Jan. 23, 2020 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of...
January 13, 2020 07:00 ET | Source: Organogenesis Holdings Inc.

Organogenesis Holdings Inc. Reports Preliminary Revenue Results for the Fourth Quarter and Fiscal Year 2019

CANTON, Mass., Jan. 13, 2020 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of...
November 21, 2019 22:04 ET | Source: Organogenesis Holdings Inc.

Organogenesis Holdings Inc. Announces Pricing of Public Offering of Class A Common Stock

CANTON, Mass., Nov. 21, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of...
November 19, 2019 16:01 ET | Source: Organogenesis Holdings Inc.

Organogenesis Holdings Inc. Announces Proposed Public Offering of Class A Common Stock

CANTON, Mass., Nov. 19, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of...
November 12, 2019 16:05 ET | Source: Organogenesis Holdings Inc.

Organogenesis Holdings Inc. Reports Third Quarter and Nine Months of 2019 Financial Results

CANTON, Mass., Nov. 12, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of...
October 11, 2019 16:05 ET | Source: Organogenesis Holdings Inc.

Latest Advanced Wound Care Research from Organogenesis Highlighted at SAWC Fall 2019

CANTON, Mass. and LAS VEGAS, Oct. 11, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture and...
October 05, 2019 09:00 ET | Source: Organogenesis Holdings Inc.

New ReNu® Data from Organogenesis Highlighted at ICRS 2019 World Congress

CANTON, Mass. and VANCOUVER, British Columbia, Oct. 05, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development,...
September 17, 2019 07:30 ET | Source: Organogenesis Holdings Inc.

Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2019 Financial Results on November 12, 2019

CANTON, Mass., Sept. 17, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization...